Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses

被引:0
|
作者
Mdluli, Thembi [1 ,2 ]
Wollen-Roberts, Suzanne [1 ,2 ]
Merbah, Melanie [1 ,2 ]
Beckman, Bradley [1 ,2 ]
Li, Yifan [1 ,2 ]
Alrubayyi, Aljawharah [1 ,2 ]
Curtis, Daniel J. [1 ,2 ]
Shubin, Zhanna [1 ,2 ,15 ]
Barrera, Michael D. [1 ,2 ]
Boeckelman, Jacob [1 ,2 ]
Duncan, Shayla [1 ,2 ]
Thapa, Pallavi [1 ,2 ]
Kim, Dohoon [1 ,2 ]
Costanzo, Margaret C. [1 ,2 ]
Bai, Hongjun [1 ,2 ]
Dearlove, Bethany L. [1 ,2 ]
Hooper, Jay W. [3 ]
Kwilas, Steven A. [3 ]
Paquin-Proulx, Dominic [1 ,2 ]
Eller, Michael A. [1 ,2 ,16 ]
Eller, Leigh Anne [1 ,2 ]
Kibuuka, Hannah [4 ]
Mwesigwa, Betty [4 ]
Kosgei, Josphat [5 ,6 ]
Sawe, Fredrick [5 ,6 ]
Oyieko, Janet [5 ,6 ]
Ntinginya, Nyanda [7 ]
Mwakisisile, Joel [7 ]
Jani, Ilesh [8 ]
Viegas, Edna [8 ]
Iroezindu, Michael [1 ,9 ]
Akintunde, Akindiran [2 ,9 ,10 ]
Paolino, Kristopher [11 ,12 ]
Robb, Merlin L. [1 ,2 ]
Ward, Lucy [13 ]
McLean, Chelsea [14 ]
Luhn, Kerstin [14 ]
Robinson, Cynthia [14 ]
Ake, Julie A. [1 ]
Rolland, Morgane [1 ,2 ]
机构
[1] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA
[2] Henry M Jackson Fdn Advancement Mil Med Inc, Bethesda, MD 20817 USA
[3] US Army Med Res Inst Infect Dis USAMRIID, Ft Detrick, MD 21702 USA
[4] Makerere Univ, Walter Reed Project, Kampala, Uganda
[5] Henry M Jackson Fdn Med Res Int, Nairobi, Kenya
[6] Kenya Govt Med Res Ctr, US Army Med Res Directorate Africa, Kericho, Kenya
[7] Natl Inst Med Res, Mbeya Med Res Ctr, Mbeya, Tanzania
[8] Polana Can Hlth Res & Training Ctr, Maputo, Mozambique
[9] Henry M Jackson Fdn Med Res Int, Abuja, Nigeria
[10] US Army Med Res Directorate Africa, Abuja, Nigeria
[11] Walter Reed Army Inst Res, Clin Trials Ctr, Silver Spring, MD 20910 USA
[12] SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA
[13] US Dept Def DOD Joint Program Execut Off Chem, Joint Project Manager Chem, Biol, Ft Detrick, MD 21702 USA
[14] Janssen Vaccines & Prevent, Leiden, Netherlands
[15] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA
[16] Natl Inst Allergy & Infect Dis, Vaccine Res Program, Div AidS, NIH, Bethesda, MD 20892 USA
关键词
2-DOSE HETEROLOGOUS AD26.ZEBOV; PROTECTS NONHUMAN-PRIMATES; OPEN-LABEL; MEDIATED PROTECTION; MONOCLONAL-ANTIBODY; VACCINES; IMMUNOGENICITY; CHALLENGE; REGIMEN; SAFETY;
D O I
10.1126/scitranslmed.adq2496
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Janssen Ebola virus (EBOV) vaccine consists of the adenovirus type 26 vector encoding the EBOV glycoprotein (GP) (Ad26.ZEBOV) and the modified vaccinia Ankara (MVA) vector encoding GP from EBOV, Sudan virus, and Marburg virus and nucleoprotein from Tai Forest virus (MVA-BN-Filo) administered 8 weeks later. We conducted a systems immunology analysis of antibody-mediated and cellular immune responses induced after two immunizations with either vaccine used first. The response to vaccination was EBOV GP specific and defined by high antibody binding, Fc effector, and neutralizing responses with CD4 T cell responses also contributing. The vaccine-induced antibody profile did not distinguish people living with or without HIV-1. Samples from 48 survivors and 121 contacts from the 2007 Ugandan Bundibugyo virus epidemic also showed minimal cross-reactivity to other filovirus proteins after infection and exposure. The lack of cross-reactivity suggests that different multivalent vaccine candidates are required to provide broad protection across filoviruses.
引用
收藏
页数:16
相关论文
共 49 条
  • [31] Human papilloma virus vaccination induces strong human papilloma virus specific cell-mediated immune responses in HIV-infected adolescents and young adults
    Rainone, Veronica
    Giacomet, Vania
    Penagini, Francesca
    Fabiano, Valentina
    Calascibetta, Francesca
    Mameli, Chiara
    Pisanelli, Stefania
    Zuccotti, Gian Vincenzo
    Clerici, Mario
    Trabattoni, Daria
    AIDS, 2015, 29 (06) : 739 - 743
  • [32] Hepatitis C virus-specific cellular and humoral immune responses following immunization with a multi-epitope fusion protein
    Qiu, Feng
    Bi, Shengli
    Wang, Yue
    Guo, Minzhuo
    Yi, Yao
    Chen, Siyong
    Guo, Yu
    Shen, Liping
    Jia, Zhiyuan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 29 (01) : 12 - 17
  • [33] Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide™ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets
    Tabynov, Kairat
    Sansyzbay, Abylay
    Tulemissova, Zhanara
    Tabynov, Kaissar
    Dhakal, Santosh
    Samoltyrova, Aigul
    Renukaradhya, Gourapura J.
    Mambetaliyev, Muratbay
    VETERINARY MICROBIOLOGY, 2016, 192 : 81 - 89
  • [34] Assays for the Evaluation of the Immune Response to Marburg and Ebola Sudan Vaccination-Filovirus Animal Nonclinical Group Anti-Marburg Virus Glycoprotein Immunoglobulin G Enzyme-Linked Immunosorbent Assay and a Pseudovirion Neutralization Assay
    Rudge Jr, Thomas L.
    Machesky, Nicholas J.
    Sankovich, Karen A.
    Lemmon, Erin E.
    Badorrek, Christopher S.
    Overman, Rachel
    Niemuth, Nancy A.
    Anderson, Michael S.
    VACCINES, 2022, 10 (08)
  • [35] West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses
    Capone, Giovanni
    Lucchese, Guglielmo
    Calabro, Michele
    Kanduc, Darja
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2013, 35 (01) : 64 - 70
  • [36] A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges
    Dupuy, Lesley C.
    Richards, Michelle J.
    Livingston, Brian D.
    Hannaman, Drew
    Schmaljohn, Connie S.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [37] Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice
    Huret, Christophe
    Desjardins, Delphine
    Miyalou, Mathilde
    Levacher, Beatrice
    Zin, Martin Amadoudji
    Bonduelle, Olivia
    Combadiere, Behazine
    Dalba, Charlotte
    Klatzmann, David
    Bellier, Bertrand
    VACCINE, 2013, 31 (11) : 1540 - 1547
  • [38] Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
    Dong, Wei
    Bhide, Yoshita
    Sicca, Federica
    Meijerhof, Tjarko
    Guilfoyle, Kate
    Engelhardt, Othmar G.
    Boon, Louis
    de Haan, Cornelis A. M.
    Carnell, George
    Temperton, Nigel
    de Vries-Idema, Jacqueline
    Kelvin, David
    Huckriede, Anke
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [39] Prime-Boost Vaccination with Recombinant Mumps Virus and Recombinant Vesicular Stomatitis Virus Vectors Elicits an Enhanced Human Immunodeficiency Virus Type 1 Gag-Specific Cellular Immune Response in Rhesus Macaques
    Xu, R.
    Nasar, F.
    Megati, S.
    Luckay, A.
    Lee, M.
    Udem, S. A.
    Eldridge, J. H.
    Egan, M. A.
    Emini, E.
    Clarke, D. K.
    JOURNAL OF VIROLOGY, 2009, 83 (19) : 9813 - 9823
  • [40] IMMUNIZATION WITH PURIFIED N1 AND N2 INFLUENZA-VIRUS NEURAMINIDASES DEMONSTRATES CROSS-REACTIVITY WITHOUT ANTIGENIC-COMPETITION
    JOHANSSON, BE
    KILBOURNE, ED
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) : 2358 - 2361